Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance
- 31 March 1994
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 10, S73-S81
- https://doi.org/10.1016/0169-5002(94)91669-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Peripheral Airway Cell Marker Expression in Non-Small Cell Lung Carcinoma: Association with Distinct Clinicopathologic FeaturesAmerican Journal of Clinical Pathology, 1992
- Establishment of Tumor Cell Lines as an Independent Prognostic Factor for Survival Time in Patients With Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Photodynamic Killing of Human Squamous Cell Carcinoma Cells Using a Monoclonal Antibody-Photosensitizer ConjugateJNCI Journal of the National Cancer Institute, 1991
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- A Phase II Trial of Carboplatin (CBDCA) in Small-Cell and Non-Small-Cell Lung Cancer with Correlation to In Vitro Analysis of CytotoxicityAmerican Journal of Clinical Oncology, 1990
- Neuroendocrine Differentiation in Endocrine and Nonendocrine Lung CarcinomasAmerican Journal of Clinical Pathology, 1988
- Mutational Activation of the K-rasOncogeneNew England Journal of Medicine, 1987
- Treatment of non-small-cell lung cancer.Journal of Clinical Oncology, 1986
- Combination versus single agent chemotherapy: A review of the basis for selection of drug treatment of cancerCancer, 1975
- “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric originCancer, 1953